ACTRN12613001275752尚未招募2 期
The effect of supplementary oral 5-hydroxytriptophan plus other essential elements (Dr Daniel capsule) on severity of depression, quality of life and the level of urinary 5-Hydroxyindoleacetic acid in patients with major depression on chronic selective serotonin reuptake inhibitors
Daniel F Fouladi0 个研究点目标入组 240 人开始时间: 2013年11月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Patients with major depression on chronic (over 6 months) selective serotonin reuptake inhibitors
排除标准
- •Patients on anti-depressive medications other than SSIRs, patients with carcinoids, renal disease, or malabsorption.
研究者
相似试验
已完成
不适用
The effect of 5-hydroxytryptamine-3 receptor antagonists on opioid-induced hypotension or bradycardia at anesthesia inductioNeoplasmsKCT0006543Konkuk University Medical Center200
尚未招募
2 期
Effect of supplementary oral L-tyrosin plus 5-hydroxytriptophan on severity of Parkinson's Disease; a clinical trialNeurological - Parkinson's diseaseAlternative and Complementary Medicine - Other alternative and complementary medicineParkinson's DiseaseACTRN12613001276741Daniel F Fouladi153
招募中
3 期
5-hydroxytryptophan in treatment of moderate to severe OCDObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT20090117001556N106Tehran University of Medical Sciences50
已完成
不适用
Effects of sub chronic oral tryptophan administrations on stress-induced mood and eating behaviour in healthy female volunteers differing in the 5-HTTLPR genotypeemotional eatingstress-induced eating10003018NL-OMON37605niversiteit Maastricht120
招募中
3 期
Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19IRCT20200401046909N2Tehran University of Medical Sciences540